What is the equity of Abcam this year?
Abcam has equity of 656.1 M GBP this year.
Abcam Equity 2024
Abcam Equity
656.1 M GBP
Ticker
ABC.L
ISIN
GB00B6774699
WKN
A1C605
In 2024, Abcam's equity was 656.1 M GBP, a 0% increase from the 0 GBP equity in the previous year.
Abcam Aktienanalyse
What does Abcam do?
Abcam PLC is an internationally operating company specializing in the development, manufacturing, and distribution of antibodies and other reagents for life science research. History: Abcam was founded in 1998 by Jonathan Milner, a biologist and cancer researcher who had experienced using antibodies in research. Recognizing a need for high-quality and reliable reagents in this field, he decided to start his own company. In the years following its founding, Abcam grew rapidly and established itself as one of the leading providers of antibodies. In 2005, the company went public on the London Stock Exchange, raising capital for further expansion. Since then, Abcam has made numerous acquisitions and expanded its product portfolio. Business model: Abcam's business model is based on selling antibodies and other reagents to research institutions, universities, and pharmaceutical companies. The company relies on an extensive network of suppliers and partners to offer a wide range of products. Another important aspect of the business model is the online marketing of Abcam's products. The company operates several websites where customers can browse and order the entire product range. To better understand customer needs, Abcam also conducts regular customer surveys and feedback. Divisions: Abcam offers a wide range of products and services, which are grouped into various divisions: Antibodies: The antibodies division is Abcam's core area, encompassing a variety of monoclonal and polyclonal antibodies for various applications. Proteins: Abcam also offers a wide range of proteins for research in areas such as cancer, neurology, and metabolic diseases. Reagents: In addition to antibodies and proteins, Abcam provides a variety of reagents, including kits for biomarker or enzyme activity determination. Services: Abcam also offers a range of services, including custom antibody development, protein expression, and assay development. Products: Abcam offers a wide range of products for use in various areas of life science research. Some of the most well-known products include: Rabbit monoclonal antibodies: These antibodies are highly specific and sensitive, making them valuable tools in cancer research. Chromatin & nucleic acid purification kits: These kits enable efficient purification of DNA, RNA, and chromatin, which is essential for many genomic and epigenomic applications. ELISA kits: Abcam offers a variety of ELISA kits for the determination of biomarkers and other target molecules. Overall, Abcam is a leading provider of antibodies and other reagents for life science research. Through constant innovation and expansion, the company has successfully grown its business in recent years and is now well-positioned worldwide. Abcam ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Abcam's Equity
Abcam's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Abcam's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Abcam's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Abcam's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Abcam’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Abcam stock
What was the equity of Abcam compared to the previous year?
The equity of Abcam has increased/decreased by 0% decreased compared to the previous year.
What impact does a high equity have on investors of Abcam?
A high equity is advantageous for investors of Abcam as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Abcam?
A low equity can be a risk for investors of Abcam, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Abcam affect the company?
An increase in equity of Abcam can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Abcam affect the company?
A reduction in equity of Abcam can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Abcam?
Some factors that can affect the equity of Abcam include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Abcam so important for investors?
The equity of Abcam is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Abcam take to change the equity?
To change equity, Abcam can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Abcam pay?
Over the past 12 months, Abcam paid a dividend of 0.04 GBP . This corresponds to a dividend yield of about 0.29 %. For the coming 12 months, Abcam is expected to pay a dividend of 0.49 GBP.
What is the dividend yield of Abcam?
The current dividend yield of Abcam is 0.29 %.
When does Abcam pay dividends?
Abcam pays a quarterly dividend. This is distributed in the months of December, April, December, April.
How secure is the dividend of Abcam?
Abcam paid dividends every year for the past 4 years.
What is the dividend of Abcam?
For the upcoming 12 months, dividends amounting to 0.49 GBP are expected. This corresponds to a dividend yield of 4 %.
In which sector is Abcam located?
Abcam is assigned to the 'Health' sector.
Wann musste ich die Aktien von Abcam kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Abcam from 4/17/2020 amounting to 0.036 GBP, you needed to have the stock in your portfolio before the ex-date on 3/19/2020.
When did Abcam pay the last dividend?
The last dividend was paid out on 4/17/2020.
What was the dividend of Abcam in the year 2023?
In the year 2023, Abcam distributed 0 GBP as dividends.
In which currency does Abcam pay out the dividend?
The dividends of Abcam are distributed in GBP.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Abcam stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Abcam
Our stock analysis for Abcam Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Abcam Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
